Ritter Pharma Revenue, Profits - RTTR Annual Income Statement

Add to My Stocks
$1.94 $0.14 (7.78%) RTTR stock closing price Sep 21, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Ritter Pharma stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. Like any other income statement, the RTTR income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue decline of 0 when compared to the same period in the past. Along with Ritter Pharma assets and Ritter Pharma free cash flow, Ritter Pharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $-7.86M and the 2017 revenue is $-.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec2017201620152014
Ritter Pharma Revenues or Net Sales
----
Cost Of Goods Sold (COGS)----
Ritter Pharma Gross Profit
----
Research & Development Expense2.87M13.29M2.26M-
Selling General & Admin Expense5.02M5.15M6.64M-
Income Before Depreciation Depletion Amortization-7.9M-18.44M-8.9M-
Depreciation Depletion Amortization----
Non Operating Income----
Interest Expense----
Ritter Pharma Pretax Income
-7.86M-18.38M-8.78M-
Provision for Income Taxes----
MinorityInterest----
Investment Gains Losses----
Other Income----
Income Before Extraordinaries & Disc Operations-7.86M-18.38M-8.78M-
Extraordinary Items & Discontinued Operations----
Ritter Pharma Profit/ Loss (Net Income)
-7.86M-18.38M-8.78M-
Average Shares used to compute Diluted EPS2.22M---
Average Shares used to compute Basic EPS2.22M---
Income Before Nonrecurring Items-10.98M-18.39M-8.79M-
Income from Nonrecurring Items----
Ritter Pharma Earnings Per Share Basic Net
-5.00-20.40-31.10-
Ritter Pharma Earnings Per Share Diluted Net
-5.00-20.40-31.10-
EPS Diluted Before Nonrecurring Items-5.00-20.40-31.10-
Preferred Dividends Acc Pd----
Dividends Common----
Dividend Per Share Common0.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

The key things to look for in an income statement while doing Ritter Pharma stock analysis are:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that RTTR stock has a topline or revenue of $- for 2017 as per this Ritter Pharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: Most businesses like Ritter Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The RTTR financials along with Ritter Pharma historical stock prices provide a lot of details about the firm.

Ritter Pharma Income Statement - Key Financial Ratios